Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
Lars Schlotawa(University of Göttingen), Jutta Gärtner(German Center for Pediatric and Adolescent Rheumatology)
Cited by 17
Related Papers
Genetics of intellectual disability in consanguineous families
|Molecular Psychiatry|2018|217
Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency
|Brain|2012|129
Mutations in SLC33A1 Cause a Lethal Autosomal-Recessive Disorder with Congenital Cataracts, Hearing Loss, and Low Serum Copper and Ceruloplasmin
|The American Journal of Human Genetics|2012|105
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
|Multiple Sclerosis Journal|2022|103